https://wiki.tradeville.ro/index.php?action=history&feed=atom&title=Akouos%2C_Inc.Akouos, Inc. - Revizia istoricului2026-04-11T15:37:49ZIstoricul versiunilor pentru această pagină din wikiMediaWiki 1.39.2https://wiki.tradeville.ro/index.php?title=Akouos,_Inc.&diff=405667&oldid=prevAdmin: Pagină nouă: Pagina dedicata companiei Akouos, Inc. listata cu simbolul US.AKUS ==Descriere companie== Akouos Inc.(www.akouos.com) is a precision genetic medicine company. The Company is focused on developing gene therapies with the potential to restore, improve, and preserve high-acuity physiologic hearing for people worldwide who live with disabling hearing loss. The Company has developed a precision genetic medicine platform that incorporates a vector library consisting of variants of...2024-09-18T13:36:36Z<p>Pagină nouă: Pagina dedicata companiei Akouos, Inc. listata cu simbolul US.AKUS ==Descriere companie== Akouos Inc.(www.akouos.com) is a precision genetic medicine company. The Company is focused on developing gene therapies with the potential to restore, improve, and preserve high-acuity physiologic hearing for people worldwide who live with disabling hearing loss. The Company has developed a precision genetic medicine platform that incorporates a vector library consisting of variants of...</p>
<p><b>Pagină nouă</b></p><div>Pagina dedicata companiei Akouos, Inc. listata cu simbolul US.AKUS<br />
<br />
==Descriere companie==<br />
Akouos Inc.(www.akouos.com) is a precision genetic medicine company. The Company is focused on developing gene therapies with the potential to restore, improve, and preserve high-acuity physiologic hearing for people worldwide who live with disabling hearing loss. The Company has developed a precision genetic medicine platform that incorporates a vector library consisting of variants of a small virus commonly used in gene therapy, known as adeno-associated virus (AAV) and a delivery approach. The Company is focused on executing on its strategic initiatives, which include the advancement of its lead product candidate, AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene; expansion of its pipeline to include programs focused on other monogenic conditions as well as inner ear conditions of complex etiology, such as AK-antiVEGF for vestibular schwannoma; and development of internal manufacturing capabilities, and a commercial infrastructure.<br />
<br />
==Grafic actiuni companie==<br />
<iframe key="tradeville" path="graficSimbol/US.AKUS" /><br />
<br />
==Ultimele stiri despre Akouos, Inc. (US.AKUS)==<br />
<dynamicpagelist><br />
category=US.AKUS<br />
count=10<br />
order=descending<br />
addfirstcategorydate=false<br />
</dynamicpagelist><br />
<br />
[[Categorie:US.AKUS]][[Categorie:Stiri despre companii]]</div>Admin